| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/25/2008 | US20080317754 Human Osteoclast Derived Cathepsin |
| 12/25/2008 | US20080317750 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/25/2008 | US20080317740 Use of Nk Cell Inhibition to Facilitate Persistence of Engrafted Mhc-I-Negative Cells |
| 12/25/2008 | US20080317739 Method for Treating Skeletal Disorders Resulting from Fgfr Malfunction |
| 12/25/2008 | US20080317699 Chemically modified dendrimers |
| 12/24/2008 | WO2008156685A2 Tendon stem cells |
| 12/24/2008 | WO2008156645A2 Pharmaceutical compositions and uses |
| 12/24/2008 | WO2008156220A1 Repair and treatment of bone defect by using cells induced by factor produced by chondrocyte having hypertrophic ability and scaffold |
| 12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/24/2008 | WO2008156069A1 Screening method for antibody and antibody obtained by the method |
| 12/24/2008 | WO2008155520A2 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
| 12/24/2008 | WO2008154814A1 OPTIMIZED TACI-Fc FUSION PROTEINS |
| 12/24/2008 | WO2008131154A3 Fibrin compositions containing strontium compounds |
| 12/24/2008 | WO2008048866A3 Bicyclic heteroaromatic compounds |
| 12/24/2008 | EP2006681A1 Rheumatoid arthritis test method and treating method |
| 12/24/2008 | EP2004696A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them |
| 12/24/2008 | EP2004692A1 Treatment of multiple sclerosis and/or rheumatoid arthritis |
| 12/24/2008 | EP2004629A2 Benzimidazole derivatives |
| 12/24/2008 | EP2004164A1 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 12/24/2008 | EP2004157A2 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, as well as combination therapy relating thereto |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | DE20321698U1 Medikament zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin-D-Derivats Medicament for increasing the bioavailability of alendronate or another bisphosphonate by administration of a predose of a vitamin D-derivative |
| 12/24/2008 | CN101328159A Taxone precursor anti-cancer drugs, medicinal composition and use thereof |
| 12/24/2008 | CN101327327A PEGylated recombined Aspergillus flavus uricoxidase coupling compound and preparation technique |
| 12/24/2008 | CN101327316A Formulation for treating and preventing acalcerosis |
| 12/24/2008 | CN101327308A Chinese herbal medicine for treating hyperosteogeny |
| 12/24/2008 | CN101327288A Method for preparing Liaoyuanqili super fine powder |
| 12/24/2008 | CN101327287A Method for preparing Liaoyuanqili ultramicro powder |
| 12/24/2008 | CN101327280A Chinese medicine for treating paralysis |
| 12/24/2008 | CN101327269A Use of stasis-dispersing medicament composition in preparing medicament for treating arthritis |
| 12/24/2008 | CN101327265A Medicament for treating chronic soft tissue injury |
| 12/24/2008 | CN101327259A Medicament for treating protrusion of lumbar vertebral disc |
| 12/24/2008 | CN101327257A Chinese medicine preparation for treating rheumatic arthritis and rheumatoid arthritis |
| 12/24/2008 | CN101327256A Medicament for treating rheumatism and rheumatoid and preparation thereof |
| 12/24/2008 | CN101327234A Rheumatalgia-relieving acetanilid |
| 12/24/2008 | CN101327227A Medicine for treating rheumatoild disease |
| 12/24/2008 | CN101327223A Medicament for treating osteonecrosis |
| 12/24/2008 | CN101327197A Sustained release drug delivery devices |
| 12/24/2008 | CN101327188A Bisphosphonates microemulsion and preparation method thereof |
| 12/24/2008 | CN100445300C GLP-1 fusion protein and its preparation method and medicinal uses |
| 12/24/2008 | CN100444882C Capsules for zhongtongling for bone fracture and soft tissue injury and their making method |
| 12/24/2008 | CN100444867C Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as estrofen-like organ-selective medicament without uteroetropic effects |
| 12/24/2008 | CN100444856C Medicine for treating femur osteonecrosis and its preparation method |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CN100444835C Tendon-relaxing blood circulation-activating capsule and preparation process thereof |
| 12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
| 12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
| 12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
| 12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 12/23/2008 | US7468268 Nucleic acid molecules encoding osteoclastogenesis inhibitory factor proteins |
| 12/23/2008 | US7468194 Administering liposomes containing povidone iodine for therapy of bacterial infection |
| 12/23/2008 | CA2364499C Means and methods for fibroblast-like or macrophage-like cell transduction |
| 12/23/2008 | CA2334520C Treatment of immune diseases |
| 12/23/2008 | CA2314817C Synergistic agents for enhancing tissue repair |
| 12/23/2008 | CA2158822C Therapeutic agent for rheumatic disease |
| 12/18/2008 | WO2008153158A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 12/18/2008 | WO2008153129A1 Agent for lowering uric acid level |
| 12/18/2008 | WO2008153072A1 Gene sensitive to bone/joint disease and use thereof |
| 12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |
| 12/18/2008 | WO2008152792A1 Osteoporosis susceptibility gene, and method for determination of risk of being suffering from osteoporosis |
| 12/18/2008 | WO2008152423A2 Treatment of inflammation or autoimmune diseases with sulphated compounds |
| 12/18/2008 | WO2008152334A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 12/18/2008 | WO2008152015A1 Composition for the improvement of functional difficulties due to articular cartilage disorders |
| 12/18/2008 | WO2008151898A1 Disaccharides for the treatment of tendons, ligaments and bones |
| 12/18/2008 | WO2008151512A1 Site-specific pegylated linear salmon calcitonin derivatives |
| 12/18/2008 | WO2008134513A3 Copper lowering treatment of autoimmune diseases |
| 12/18/2008 | WO2008124907A3 Resveratrol-containing composition for modulating bone formation |
| 12/18/2008 | US20080312449 New Compounds |
| 12/18/2008 | US20080312314 Alpha crystalline form of strontium ranelate |
| 12/18/2008 | US20080312293 2-Arylpropionic Acid Derivatives and Pharmaceutical Compositions Containing Them |
| 12/18/2008 | US20080312270 Compounds and methods useful for treating asthma and allergic inflammation |
| 12/18/2008 | US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 12/18/2008 | US20080312229 Organic Compounds |
| 12/18/2008 | US20080312219 Biologically active methylene blue derivatives |
| 12/18/2008 | US20080312215 Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
| 12/18/2008 | US20080312199 Treatments of therapy resistant diseases and drug combinations for treating the same |
| 12/18/2008 | US20080312186 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 12/18/2008 | US20080312156 In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair |
| 12/18/2008 | US20080312153 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 12/18/2008 | US20080312149 Health Food and Pharmaceutical Composition for Amelioration of Disease Induced by Metabolic Disorder in Cartilage |
| 12/18/2008 | US20080312145 Agent for Regulating Bone Formation |
| 12/18/2008 | US20080312142 Composition for Increasing Body Height |
| 12/18/2008 | US20080311185 Deregulated Genes and/or Processes in Inflammatory Arthritis |
| 12/18/2008 | US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity |
| 12/18/2008 | US20080311121 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 12/18/2008 | US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof |
| 12/18/2008 | US20080311115 Atherosclerosis, rheumatoid arthritis (RA), psoriasis, psoriatic arthritis, bacteria-induced gastric ulcer, and acute renal failure |
| 12/18/2008 | US20080311114 Use of morphogenic proteins to treat human disc disease |
| 12/18/2008 | US20080311101 Method to Reduce Oxalate Concentration by Administration of Oxalate Oxidase Crystals |
| 12/18/2008 | US20080311085 Method for treating an animal having damaged tissue structure |
| 12/18/2008 | US20080311080 Bifidobacterium in the treatment of inflammatory disease |
| 12/18/2008 | DE102007043186A1 Cyclohexenonverbidungen aus Antrodia camphorata zur Behandlung von Autoimmunerkrankungen From Antrodia camphorata Cyclohexenonverbidungen for the treatment of autoimmune diseases |
| 12/18/2008 | CA2689079A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 12/18/2008 | CA2688241A1 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 12/18/2008 | CA2687751A1 Disaccharides for the treatment of tendons, ligaments and bones |
| 12/17/2008 | EP2002846A2 Combination therapy using an IL-1 inhibitor for treating IL-1 mediated diseases |